Related Experiment Video
Updated: Jul 16, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Improving Clinician Confidence in Insulin Prescriptions at Discharge for Individuals With Newly Diagnosed Type 1
Haris Shoaib1, Yunus K Hussain1, Shahida Ahmed2
1Medicine, Basildon and Thurrock University Hospital, Basildon, GBR.
Insights
Pediatric doctors
Area of Science:
- Pediatric Endocrinology
- Diabetes Management
- Clinical Quality Improvement
Background:
- Low confidence in prescribing multiple daily injections (MDI) for pediatric type 1 diabetes mellitus (T1DM) identified among clinicians.
- Existing local guidelines were perceived as inaccessible and not user-friendly.
Purpose of the Study:
- To develop and evaluate tailored prescription guidance to enhance clinician confidence in MDI discharge prescriptions.
- To improve the accuracy and accessibility of MDI prescribing information for pediatric doctors.
Main Methods:
- Adapted existing local guidelines into a concise, practical MDI prescription tool with a checklist.
- Intervention delivered to pediatric doctors in a single unit; confidence assessed via pre- and post-intervention questionnaires (Likert Scale).
- Guidance disseminated via email and displayed prominently; feedback collected on accessibility and impact.
Main Results:
- Confidence in MDI prescribing significantly increased from a mean score of 1.9 to 4.0 (p<0.0001).
- 90% of doctors routinely consult guidelines, but 50% found them inaccessible.
- 90% felt the new guidelines optimized patient care.
Conclusions:
- Locally tailored, accessible MDI prescription guidance significantly boosts pediatric doctor confidence.
- Adapted guidelines integrated into junior doctor induction and hospital intranet.
- Continuous improvement and updates are planned to further enhance clinician confidence in T1DM management.
Abstract:
Background In a questionnaire, we found that pediatric clinicians at Basildon and Thurrock University Hospital (BTUH) have low confidence levels in prescribing multiple daily injections (MDI) for newly diagnosed pediatric patients with type 1 diabetes mellitus. We designed and evaluated locally tailored prescription guidance to improve confidence in MDI discharge prescriptions for pediatric doctors of all grades. Methods We designed a prescription guidance tool by adapting existing local guidelines to improve clinician familiarity with MDI prescriptions and prevent prescription errors. The intervention was delivered in a single pediatric unit to doctors of all levels. Feedback was collected, and the clinicians' confidence in their MDI prescriptions was evaluated before and after the intervention. Questionnaires were distributed to all pediatric doctors within the unit to assess their confidence in prescribing MDIs using a five-point Likert Scale. Furthermore, the questionnaires aimed to determine whether clinicians regularly consulted the existing local guidelines. Local guidelines were adapted in consultation with the local pediatric diabetic multidisciplinary team (MDT) and with reference to the East of England Pediatric Diabetes Network to present MDI guidance in a more concise format, which includes an example MDI discharge medication checklist. Following approval by the local guidelines management group, additional changes were made to enhance the practicality and accessibility of the discharge prescription guidance for clinicians. These guidelines were distributed to the pediatric MDT via email and displayed in visible areas of the department. Results Out of the 13 doctors surveyed, 10 provided pre- and post-intervention feedback (77%). Statistical significance was calculated using unpaired t-tests. Ninety percent of pediatric doctors routinely refer to local guidelines for guidance on MDI prescriptions. However, 50% of respondents felt that existing local guidelines were not easily accessible, given the time and effort required to locate them. The mean confidence score for completing MDI prescriptions at discharge before the intervention was 1.9 (SD: 0.83). After the intervention, it increased to 4 (SD: 0.63) (95% CI: 2.79-1.41, p<0.0001). Ninety percent of pediatric doctors felt that the design and display of the MDI guidelines optimized patient care. Conclusions Following the presentation of the project at a local audit and quality improvement (QI) meeting, the adapted guidelines were included in the junior doctor induction program at BTUH and made accessible on the local intranet. The production of locally tailored prescription guidance for MDI prescriptions at discharge has led to an increase in the confidence of pediatric doctors when writing their prescriptions. We aimed to continue updating this guidance as necessary and making further developments to enhance clinician confidence.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Dipeptidyl Peptidase 4 Inhibitors

